BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 30664180)

  • 1. Weighted gene co‑expression network analysis for identifying hub genes in association with prognosis in Wilms tumor.
    Wang X; Song P; Huang C; Yuan N; Zhao X; Xu C
    Mol Med Rep; 2019 Mar; 19(3):2041-2050. PubMed ID: 30664180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of key genes and associated pathways in KIT/PDGFRA wild‑type gastrointestinal stromal tumors through bioinformatics analysis.
    Wang WJ; Li HT; Yu JP; Li YM; Han XP; Chen P; Yu WW; Chen WK; Jiao ZY; Liu HB
    Mol Med Rep; 2018 Nov; 18(5):4499-4515. PubMed ID: 30221743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis.
    Li F; Guo P; Dong K; Guo P; Wang H; Lv X
    J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
    Chen X; Pan Y; Yan M; Bao G; Sun X
    Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
    Li J; Liu X; Cui Z; Han G
    Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentially Expressed Gene Screening, Biological Function Enrichment, and Correlation with Prognosis in Non-Small Cell Lung Cancer.
    Huang H; Huang Q; Tang T; Zhou X; Gu L; Lu X; Liu F
    Med Sci Monit; 2019 Jun; 25():4333-4341. PubMed ID: 31181055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatics analysis of gene expression profile data to screen key genes involved in intracranial aneurysms.
    Guo T; Hou D; Yu D
    Mol Med Rep; 2019 Nov; 20(5):4415-4424. PubMed ID: 31545495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of hub genes and pathways in adrenocortical carcinoma by integrated bioinformatic analysis.
    Guo J; Gu Y; Ma X; Zhang L; Li H; Yan Z; Han Y; Xie L; Guo X
    J Cell Mol Med; 2020 Apr; 24(8):4428-4438. PubMed ID: 32147961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening of the prognostic targets for breast cancer based co-expression modules analysis.
    Liu H; Ye H
    Mol Med Rep; 2017 Oct; 16(4):4038-4044. PubMed ID: 28731166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the potential novel biomarkers as susceptibility gene for Wilms tumor.
    Liu L; Song Z; Gao XD; Chen X; Wu XB; Wang M; Hong YD
    BMC Cancer; 2021 Mar; 21(1):316. PubMed ID: 33765954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of key genes and pathways involved in microsatellite instability in colorectal cancer.
    Yu C; Hong H; Zhang S; Zong Y; Ma J; Lu A; Sun J; Zheng M
    Mol Med Rep; 2019 Mar; 19(3):2065-2076. PubMed ID: 30664178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis.
    Wang Y; Chen L; Wang G; Cheng S; Qian K; Liu X; Wu CL; Xiao Y; Wang X
    J Cell Physiol; 2019 Jul; 234(7):10225-10237. PubMed ID: 30417363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of 40S ribosomal protein S8 as a novel biomarker for alcohol‑associated hepatocellular carcinoma using weighted gene co‑expression network analysis.
    Bi N; Sun Y; Lei S; Zeng Z; Zhang Y; Sun C; Yu C
    Oncol Rep; 2020 Aug; 44(2):611-627. PubMed ID: 32627011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of CCT4/ErbB signaling in nephroblastoma: Implications for a biomarker of Wilms tumor.
    Wang H; Zhang L; Liu B; Su J; Ni X
    Medicine (Baltimore); 2023 Apr; 102(15):e33219. PubMed ID: 37058032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Hub Gene GRIN1 Correlated with Histological Grade and Prognosis of Glioma by Weighted Gene Coexpression Network Analysis.
    Yang A; Wang X; Hu Y; Shang C; Hong Y
    Biomed Res Int; 2021; 2021():4542995. PubMed ID: 34840971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative genomics analysis of hub genes and their relationship with prognosis and signaling pathways in esophageal squamous cell carcinoma.
    Chen FF; Zhang SR; Peng H; Chen YZ; Cui XB
    Mol Med Rep; 2019 Oct; 20(4):3649-3660. PubMed ID: 31485619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.